{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:03:28Z","timestamp":1775793808500,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.lpm.2016.07.023","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T14:32:48Z","timestamp":1473777168000},"page":"1084-1092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P1","title":["Syndrome catastrophique des antiphospholipides (CAPS)\u00a0: revue\u00a02016"],"prefix":"10.1016","volume":"45","author":[{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laetitia","family":"Coutte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaelle","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Paule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Piette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2016.07.023_bib0265","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2016.07.023_bib0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50\u00a0patients","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2016.07.023_bib0275","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.autrev.2006.06.007","article-title":"Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors","volume":"6","author":"Bucciarelli","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2016.07.023_bib0280","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.revmed.2012.01.005","article-title":"Le syndrome catastrophique des antiphospholipides","volume":"33","author":"Costedoat-Chalumeau","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2016.07.023_bib0285","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0961203310395051","article-title":"Task force on catastrophic antiphospholipid syndrome (APS) and Non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions","volume":"20","author":"Cervera","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2016.07.023_bib0290","doi-asserted-by":"crossref","unstructured":"Taraborelli M, Reggia R, Dall\u2019Ara F, Fredi M, Andreoli L, Gerosa M, et al. Long-term outcome of patients with primary antiphospholipid syndrome: a retrospective multicenter study. Soumis 2016.","DOI":"10.1136\/annrheumdis-2015-eular.4445"},{"key":"10.1016\/j.lpm.2016.07.023_bib0295","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280\u00a0patients from the \u201cCAPS registry\u201d","volume":"32","author":"Cervera","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lpm.2016.07.023_bib0300","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.07.023_bib0305","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semarthrit.2007.08.001","article-title":"Relapsing catastrophic antiphospholipid syndrome: report of three cases","volume":"37","author":"Asherson","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2016.07.023_bib0310","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2016.07.023_bib0315","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","article-title":"Catastrophic antiphospholipid syndrome: updated diagnostic algorithms","volume":"10","author":"Erkan","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2016.07.023_bib0320","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.autrev.2015.07.009","article-title":"The role of infectious diseases in the catastrophic antiphospholipid syndrome","volume":"14","author":"Garcia-Carrasco","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2016.07.023_bib0325","first-page":"843","article-title":"Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations","volume":"29","author":"Erkan","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2016.07.023_bib0330","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ket167","article-title":"Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13\u00a0cases","volume":"52","author":"Hanouna","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2016.07.023_bib0335","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00431-011-1548-9","article-title":"Catastrophic antiphospholipid syndrome: first signs in the neonatal period","volume":"170","author":"Cabral","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.lpm.2016.07.023_bib0340","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.autrev.2013.10.004","article-title":"Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45\u00a0patients from the \u201cCAPS registry\u201d","volume":"13","author":"Berman","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2016.07.023_bib0345","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.revmed.2012.01.003","article-title":"Grossesse et syndrome des antiphospholipides","volume":"33","author":"Costedoat-Chalumeau","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2016.07.023_bib0350","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.lpm.2016.07.023_bib0355","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1182\/blood-2011-01-333617","article-title":"In vivo distribution of beta\u00a02\u00a0glycoprotein\u00a0I under various pathophysiologic conditions","volume":"118","author":"Agostinis","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2016.07.023_bib0360","first-page":"585","article-title":"Catastrophic antiphospholipid syndrome: an orchestra with several musicians","volume":"16","author":"Rodriguez-Pinto","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.lpm.2016.07.023_bib0365","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.autrev.2015.08.011","article-title":"Delineating the deranged immune system in the antiphospholipid syndrome","volume":"15","author":"van den Hoogen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2016.07.023_bib0370","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0961203309361353","article-title":"Catastrophic antiphospholipid syndrome (CAPS): update from the \u201cCAPS registry\u201d","volume":"19","author":"Cervera","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2016.07.023_bib0375","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","article-title":"The intrarenal vascular lesions associated with primary antiphospholipid syndrome","volume":"10","author":"Nochy","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2016.07.023_bib0380","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/ard.2005.037671","article-title":"The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47\u00a0patients","volume":"65","author":"Bucciarelli","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.07.023_bib0385","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/0961203307085405","article-title":"Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature","volume":"17","author":"Leroux","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2016.07.023_bib0390","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.21041","article-title":"Dermatologic manifestations of the antiphospholipid syndrome: 200\u00a0consecutive cases","volume":"52","author":"Frances","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2016.07.023_bib0395","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.revmed.2011.10.003","article-title":"Manifestations dermatologiques du syndrome des antiphospholipides","volume":"33","author":"Frances","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2016.07.023_bib0400","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/1529-0131(199807)41:7<1318::AID-ART24>3.0.CO;2-K","article-title":"Acalculous ischemic gallbladder necrosis in the catastrophic antiphospholipid syndrome","volume":"41","author":"Dessailloud","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2016.07.023_bib0405","first-page":"768","article-title":"Pancr\u00e9atites et maladies syst\u00e9miques","author":"Papo","year":"1997","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.lpm.2016.07.023_bib0410","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/jc.2012-4300","article-title":"Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16\u00a0patients","volume":"98","author":"Ramon","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2016.07.023_bib0415","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jbspin.2014.10.016","article-title":"Catastrophic antiphospholipid syndrome presenting with bilateral massive adrenal haemorrhage. A case report","volume":"82","author":"Michon","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2016.07.023_bib0420","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1002\/art.38712","article-title":"Multiple osteonecrotic lesions mimicking a piano keyboard in the spine of a patient with catastrophic antiphospholipid syndrome","volume":"66","author":"Jung","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.lpm.2016.07.023_bib0425","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1002\/art.20551","article-title":"Thrombotic thrombocytopenic purpura with severe ADAMTS-13\u00a0deficiency in two patients with primary antiphospholipid syndrome","volume":"50","author":"Amoura","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2016.07.023_bib0430","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1538-7836.2009.03335.x","article-title":"False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus","volume":"7","author":"Pauzner","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2016.07.023_bib0435","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MBC.0000000000000210","article-title":"Catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia-related diseases or chance association?","volume":"26","author":"Tun","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.lpm.2016.07.023_bib0440","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-009-0073-6","article-title":"Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome","volume":"12","author":"Cervera","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.lpm.2016.07.023_bib0445","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000\u00a0patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.07.023_bib0450","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.62.6.530","article-title":"Long term outcome of catastrophic antiphospholipid syndrome survivors","volume":"62","author":"Erkan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2016.07.023_bib0455","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semarthrit.2012.05.005","article-title":"Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses","volume":"42","author":"Espinosa","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2016.07.023_bib0460","first-page":"346","article-title":"The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus","volume":"34","author":"Bayraktar","year":"2007","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.lpm.2016.07.023_bib0465","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.revmed.2013.11.011","article-title":"Les nouveaux criteres de classification du lupus systemique (SLICC)","volume":"35","author":"Costedoat-Chalumeau","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2016.07.023_bib0470","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2016.07.023_bib0475","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/art.34440","article-title":"Induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab","volume":"64","author":"Shapira","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2016.07.023_bib0480","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/MD.0000000000000143","article-title":"Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report","volume":"93","author":"Kronbichler","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2016.07.023_bib0485","first-page":"704371","article-title":"Thirty-six-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature","volume":"2014","author":"Strakhan","year":"2014","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.lpm.2016.07.023_bib0490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/RHU.0000000000000290","article-title":"Eculizumab induces sustained remission in a patient with refractory primary catastrophic antiphospholipid syndrome","volume":"21","author":"Zikos","year":"2015","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.lpm.2016.07.023_bib0495","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/ajt.12540","article-title":"Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation","volume":"14","author":"Lonze","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.lpm.2016.07.023_bib0500","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMc0910965","article-title":"Eculizumab and renal transplantation in a patient with CAPS","volume":"362","author":"Lonze","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2016.07.023_bib0505","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0961203310389099","article-title":"Eculizumab and renal transplantation in a patient with catastrophic antiphospholipid syndrome: effect of heparin on complement activation","volume":"20","author":"Velik-Salchner","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2016.07.023_bib0510","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0032-1304718","article-title":"Update on the catastrophic antiphospholipid syndrome and the \u201cCAPS registry\u201d","volume":"38","author":"Cervera","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.lpm.2016.07.023_bib0515","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2016.07.023_bib0260","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.revmed.2012.01.010","article-title":"Le syndrome des antiphospholipides en 2012\u00a0: son h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 impose une prise en charge personnalis\u00e9e","volume":"33","author":"Costedoat-Chalumeau","year":"2012","journal-title":"Rev Med Interne"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821630210X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821630210X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:30:02Z","timestamp":1749580202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075549821630210X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S075549821630210X"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2016.07.023","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndrome catastrophique des antiphospholipides (CAPS)\u00a0: revue\u00a02016","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}